Skip to main content
Top
Published in: BMC Oral Health 1/2014

Open Access 01-12-2014 | Research article

Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders

Authors: Yen-Yun Wang, Yen-Hsuan Tail, Wen-Chen Wang, Ching-Yi Chen, Yu-Hsun Kao, Yuk-Kwan Chen, Chung-Ho Chen

Published in: BMC Oral Health | Issue 1/2014

Login to get access

Abstract

Background

Oral cancers can be preceded by clinically evident oral potentially malignant disorders (OPMDs). The current study evaluated the rate and the time of malignant transformation in the various OPMDs in a cohort of patients from southern Taiwan. Parameters possibly indicative for malignant transformation of OPMDs, such as epidemiological and etiological factors, and clinical and histopathological features were also described.

Methods

We followed-up 5071 patients with OPMDs—epithelial dysplasia with oral submucous fibrosis, epithelial dysplasia with hyperkeratosis/epithelial hyperplasia, hyperkeratosis/epithelial hyperplasia, oral submucous fibrosis, lichen planus, and verrucous hyperplasia—between 2001 and 2010 for malignant transformation.

Results

Two hundred nineteen of these 5071 OPMD patients (202 men, 17 women; mean age: 51.25 years; range: 30–81 years) developed oral cancers (179 squamous cell carcinomas; 40 verrucous carcinomas) in the same sites as the initial lesions at least 6 months after their initial biopsies. The overall transformation rate was 4.32% (mean duration of transformation: 33.56 months; range: 6–67 months). Additionally, the mean time of malignant transformation was significantly shorter for lesions with than without epithelial dysplasia. The risk of malignant transformation was 1.89 times higher for epithelially dysplastic than non-dysplastic lesions. The anatomical site of OPMD and the presence of epithelial dysplasia were significantly associated with malignant transformation. The hazard rate ratio was 1.87 times larger for tongue lesions than for buccal lesions.

Conclusion

Patients with OPMDs require long-term follow up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tang H, Wu Z, Zhang J, Su B: Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013, 7 (3): 761-766.PubMed Tang H, Wu Z, Zhang J, Su B: Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013, 7 (3): 761-766.PubMed
3.
go back to reference Tovosia S1, Chen PH, Ko AM, Tu HP, Tsai PC, Ko YC: Prevalence and associated factors of betel quid use in the Solomon Islands: a hyperendemic area for oral and pharyngeal cancer. Am J Trop Med Hyg. 2007, 77 (3): 586-590.PubMed Tovosia S1, Chen PH, Ko AM, Tu HP, Tsai PC, Ko YC: Prevalence and associated factors of betel quid use in the Solomon Islands: a hyperendemic area for oral and pharyngeal cancer. Am J Trop Med Hyg. 2007, 77 (3): 586-590.PubMed
4.
go back to reference Health Promotion Administration, Ministry of Health and Welfare: Cancer Registry Annual Report 2011 Taiwan. 2014, 3-17. Health Promotion Administration, Ministry of Health and Welfare: Cancer Registry Annual Report 2011 Taiwan. 2014, 3-17.
5.
go back to reference Scott SE, Grunfeld EA, McGurk M: The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma. Oral Oncol. 2005, 41 (4): 396-403.CrossRefPubMed Scott SE, Grunfeld EA, McGurk M: The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma. Oral Oncol. 2005, 41 (4): 396-403.CrossRefPubMed
6.
go back to reference van der Waal I: Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009, 45 (4–5): 317-323.CrossRefPubMed van der Waal I: Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009, 45 (4–5): 317-323.CrossRefPubMed
7.
go back to reference Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM: Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007, 36 (1): 25-29.CrossRefPubMed Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM: Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007, 36 (1): 25-29.CrossRefPubMed
8.
go back to reference Ho PS, Chen PL, Warnakulasuriya S, Shieh TY, Chen YK, Huang IY: Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer. 2009, 9: 260-CrossRefPubMedPubMedCentral Ho PS, Chen PL, Warnakulasuriya S, Shieh TY, Chen YK, Huang IY: Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer. 2009, 9: 260-CrossRefPubMedPubMedCentral
9.
go back to reference Pindborg JJ, Daftary DK, Mehta FS: A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol. 1977, 43 (3): 383-390.CrossRefPubMed Pindborg JJ, Daftary DK, Mehta FS: A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol. 1977, 43 (3): 383-390.CrossRefPubMed
10.
go back to reference Wright A, Shear M: Epithelial dysplasia immediately adjacent to oral squamous cell carcinomas. J Oral Pathol. 1985, 14 (7): 559-564.CrossRefPubMed Wright A, Shear M: Epithelial dysplasia immediately adjacent to oral squamous cell carcinomas. J Oral Pathol. 1985, 14 (7): 559-564.CrossRefPubMed
11.
go back to reference Schepman KP, van der Meij EH, Smeele LE, van der Waal I: Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998, 34 (4): 270-275.CrossRefPubMed Schepman KP, van der Meij EH, Smeele LE, van der Waal I: Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998, 34 (4): 270-275.CrossRefPubMed
12.
go back to reference Amagasa T, Yamashiro M, Ishikawa H: Oral leukoplakia related to malignant transformation. Oral Science International. 2006, 3 (2): 45-55.CrossRef Amagasa T, Yamashiro M, Ishikawa H: Oral leukoplakia related to malignant transformation. Oral Science International. 2006, 3 (2): 45-55.CrossRef
13.
go back to reference Gangadharan P, Paymaster JC: Leukoplakia–an epidemiologic study of 1504 cases observed at the Tata Memorial Hospital, Bombay India. Br J Cancer. 1971, 25 (4): 657-668.CrossRefPubMedPubMedCentral Gangadharan P, Paymaster JC: Leukoplakia–an epidemiologic study of 1504 cases observed at the Tata Memorial Hospital, Bombay India. Br J Cancer. 1971, 25 (4): 657-668.CrossRefPubMedPubMedCentral
14.
go back to reference Silverman S, Gorsky M, Lozada F: Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984, 53 (3): 563-568.CrossRefPubMed Silverman S, Gorsky M, Lozada F: Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984, 53 (3): 563-568.CrossRefPubMed
15.
go back to reference Liu W, Bao ZX, Shi LJ, Tang GY, Zhou ZT: Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases. Histopathology. 2011, 59 (4): 733-740.CrossRefPubMed Liu W, Bao ZX, Shi LJ, Tang GY, Zhou ZT: Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases. Histopathology. 2011, 59 (4): 733-740.CrossRefPubMed
16.
go back to reference Kumar A, Cascarini L, McCaul JA, Kerawala CJ, Coombes D, Godden D, Brennan PA: How should we manage oral leukoplakia?. Br J Oral Maxillofac Surg. 2013, 51 (5): 377-383.CrossRefPubMed Kumar A, Cascarini L, McCaul JA, Kerawala CJ, Coombes D, Godden D, Brennan PA: How should we manage oral leukoplakia?. Br J Oral Maxillofac Surg. 2013, 51 (5): 377-383.CrossRefPubMed
17.
go back to reference Ho MW, Field EA, Field JK, Risk JM, Rajlawat BP, Rogers SN, Steele JC, Triantafyllou A, Woolgar JA, Lowe D, Shaw RJ: Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. Br J Oral Maxillofac Surg. 2013, 51 (7): 594-599.CrossRefPubMed Ho MW, Field EA, Field JK, Risk JM, Rajlawat BP, Rogers SN, Steele JC, Triantafyllou A, Woolgar JA, Lowe D, Shaw RJ: Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. Br J Oral Maxillofac Surg. 2013, 51 (7): 594-599.CrossRefPubMed
18.
go back to reference Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F: Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001, 7 (1): 18-24.PubMed Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F: Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001, 7 (1): 18-24.PubMed
19.
go back to reference Pindborg JJ, Sirsat SM: Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol. 1966, 22 (6): 764-779.CrossRefPubMed Pindborg JJ, Sirsat SM: Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol. 1966, 22 (6): 764-779.CrossRefPubMed
20.
go back to reference Canniff JP, Harvey W, Harris M: Oral submucous fibrosis: its pathogenesis and management. Br Dent J. 1986, 160 (12): 429-434.CrossRefPubMed Canniff JP, Harvey W, Harris M: Oral submucous fibrosis: its pathogenesis and management. Br Dent J. 1986, 160 (12): 429-434.CrossRefPubMed
21.
go back to reference Farhi D, Dupin N: Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol. 2010, 28 (1): 100-108.CrossRefPubMed Farhi D, Dupin N: Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol. 2010, 28 (1): 100-108.CrossRefPubMed
22.
go back to reference Shen ZY, Liu W, Zhu LK, Feng JQ, Tang GY, Zhou ZT: A retrospective clinicopathological study on oral lichen planus and malignant transformation: analysis of 518 cases. Med Oral Patol Oral Cir Bucal. 2012, 17 (6): e943-e947.CrossRefPubMedPubMedCentral Shen ZY, Liu W, Zhu LK, Feng JQ, Tang GY, Zhou ZT: A retrospective clinicopathological study on oral lichen planus and malignant transformation: analysis of 518 cases. Med Oral Patol Oral Cir Bucal. 2012, 17 (6): e943-e947.CrossRefPubMedPubMedCentral
23.
go back to reference Sigurgeirsson B, Lindelof B: Lichen planus and malignancy. An epidemiologic study of 2071 patients and a review of the literature. Arch Dermatol. 1991, 127 (11): 1684-1688.CrossRefPubMed Sigurgeirsson B, Lindelof B: Lichen planus and malignancy. An epidemiologic study of 2071 patients and a review of the literature. Arch Dermatol. 1991, 127 (11): 1684-1688.CrossRefPubMed
24.
go back to reference Rodstrom PO, Jontell M, Mattsson U, Holmberg E: Cancer and oral lichen planus in a Swedish population. Oral Oncol. 2004, 40 (2): 131-138.CrossRefPubMed Rodstrom PO, Jontell M, Mattsson U, Holmberg E: Cancer and oral lichen planus in a Swedish population. Oral Oncol. 2004, 40 (2): 131-138.CrossRefPubMed
26.
go back to reference Wang YP, Chen HM, Kuo RC, Yu CH, Sun A, Liu BY, Kuo YS, Chiang CP: Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications. J Oral Pathol Med. 2009, 38 (8): 651-656.CrossRefPubMed Wang YP, Chen HM, Kuo RC, Yu CH, Sun A, Liu BY, Kuo YS, Chiang CP: Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications. J Oral Pathol Med. 2009, 38 (8): 651-656.CrossRefPubMed
27.
go back to reference Silverman S, Bhargava K, Smith LW, Malaowalla AM: Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat India. Cancer. 1976, 38 (4): 1790-1795.CrossRefPubMed Silverman S, Bhargava K, Smith LW, Malaowalla AM: Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat India. Cancer. 1976, 38 (4): 1790-1795.CrossRefPubMed
28.
go back to reference Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, Jalnawalla PN, Sinor PN, Pitkar VK, Murti PR, Irani RR, Shah HT, Kadam PM, Iyer KS, Iyer HM, Hegde AK, Chandrashekar GK, Shiroff BC, Sahiar BE, Mehta MN: Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol. 1980, 8 (6): 283-333.CrossRefPubMed Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, Jalnawalla PN, Sinor PN, Pitkar VK, Murti PR, Irani RR, Shah HT, Kadam PM, Iyer KS, Iyer HM, Hegde AK, Chandrashekar GK, Shiroff BC, Sahiar BE, Mehta MN: Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol. 1980, 8 (6): 283-333.CrossRefPubMed
Metadata
Title
Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders
Authors
Yen-Yun Wang
Yen-Hsuan Tail
Wen-Chen Wang
Ching-Yi Chen
Yu-Hsun Kao
Yuk-Kwan Chen
Chung-Ho Chen
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2014
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/1472-6831-14-99

Other articles of this Issue 1/2014

BMC Oral Health 1/2014 Go to the issue